Literature DB >> 3817763

Secretory component in pulmonary adenocarcinoma and mesothelioma.

A Kondi-Paphitis, B J Addis.   

Abstract

The distribution of secretory component was examined by an immunoperoxidase method in 40 pulmonary adenocarcinomas, 11 malignant pleural mesotheliomas and areas of normal lung adjacent to the tumours. Secretory component was demonstrated in tumour cells in 25 (67%) adenocarcinomas. Its presence correlated with the degree of differentiation but was not related to tumour pattern. In the normal lung secretory component can be demonstrated in bronchial ciliated cells, bronchial gland serous cells, bronchiolar epithelium and hyperplastic alveolar epithelium. Although not usually detectable in normal mucous cells it was frequently present in mucin-producing tumours. None of the mesotheliomas examined contained secretory component and this may be an additional useful feature in the differential diagnosis between mesothelioma and adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3817763     DOI: 10.1111/j.1365-2559.1986.tb02571.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

Review 1.  Update on special techniques in routine cytopathology.

Authors:  I D Buley
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

2.  Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis.

Authors:  Sebahat Ocak; Tetyana V Pedchenko; Heidi Chen; Frederick T Harris; Jun Qian; Vasiliy Polosukhin; Charles Pilette; Yves Sibille; Adriana L Gonzalez; Pierre P Massion
Journal:  Eur Respir J       Date:  2011-09-29       Impact factor: 16.671

Review 3.  Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review.

Authors:  S K Mohanty; P Dey
Journal:  Postgrad Med J       Date:  2003-10       Impact factor: 2.401

4.  The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma.

Authors:  Jing Ai; Qingjuan Tang; Yanlin Wu; Yang Xu; Teng Feng; Ruiyu Zhou; Yi Chen; Xin Gao; Qingfeng Zhu; Xihua Yue; Qiuming Pan; Siyun Xu; Jing Li; Min Huang; Jennifer Daugherty-Holtrop; Yuanzheng He; H Eric Xu; Jia Fan; Jian Ding; Meiyu Geng
Journal:  J Natl Cancer Inst       Date:  2011-10-24       Impact factor: 13.506

5.  Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis.

Authors:  Richard Fristedt; Jacob Elebro; Alexander Gaber; Liv Jonsson; Margareta Heby; Yulyana Yudina; Björn Nodin; Mathias Uhlén; Jakob Eberhard; Karin Jirström
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.